Invention Grant
- Patent Title: Modulation of BCL11A for treatment of hemoglobinopathies
-
Application No.: US13743399Application Date: 2013-01-17
-
Publication No.: US09228185B2Publication Date: 2016-01-05
- Inventor: Stuart H. Orkin , Vijay G. Sankaran
- Applicant: CHILDRENS MEDICAL CENTER CORPORATION , PRESIDENT AND FELLOWS OF HARVARD COLLEGE
- Applicant Address: US MA Boston US MA Cambridge
- Assignee: CHILDREN'S MEDICAL CENTER CORPORATION,PRESIDENT AND FELLOWS OF HARVARD COLLEGE
- Current Assignee: CHILDREN'S MEDICAL CENTER CORPORATION,PRESIDENT AND FELLOWS OF HARVARD COLLEGE
- Current Assignee Address: US MA Boston US MA Cambridge
- Agency: Nixon Peabody LLP
- Agent David S. Resnick
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K31/713 ; A01K67/027 ; C07K14/47 ; C07K14/805 ; C12N15/85 ; C12N15/86 ; A61K35/28 ; A61K49/00 ; C12Q1/68
Abstract:
The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies.
Public/Granted literature
- US20130129629A1 MODULATION OF BCL11A FOR TREATMENT OF HEMOGLOBINOPATHIES Public/Granted day:2013-05-23
Information query
